S. Lawhorn

Heparin associated thrombocytopenia.

J. Talley, D. Richardson, S. Lawhorn, 1995, The Journal of the Arkansas Medical Society.

Estrogen replacement therapy after coronary angioplasty in women.

J. O’Keefe, B. Mccallister, S. Lawhorn, 1997, Journal of the American College of Cardiology.

PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates.

A. Magalski, A. Kao, S. Lawhorn, 2021, Journal of cardiac failure.

Single‐center utilization of donor‐derived cell‐free DNA testing in the management of heart transplant patients

A. Magalski, A. Kao, S. Lawhorn, 2021, Clinical transplantation.

Influence of Donor Transmitted and Rapidly Progressive Coronary Vascular Disease on Long Term Outcomes After Heart Transplantation: A Contemporary Intravascular Ultrasound Analysis.

A. Magalski, D. Safley, A. Kao, 2020, Journal of cardiac failure.

A technique for the determination of left ventricular mass by signal-averaged electrocardiography

D.B. Wilson, G.W. Botteron, J.L. Vacek, 1989, Images of the Twenty-First Century. Proceedings of the Annual International Engineering in Medicine and Biology Society,.

Screening cerebrovascular patients for silent myocardial ischemia with stress testing and ambulatory left ventricular function monitor.

R. Robinson, S. Lawhorn, D. Ziegler, 1994, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

Evolution of Diagnostic and Treatment Patterns of Cardiac Sarcoidosis.

Sanjaya K. Gupta, Akshit Sharma, S. Taduru, 2020, Missouri medicine.